Latest available resultsQuarter ended June 30, 202610-Q · July 30, 2026
Filed with the SECBAXTER INTERNATIONAL INC
BAXHealthcare
Next reportOctober 28, 2026Analyst forecast 0.524 $/share
Revenue
$2.96B
▲ +5.3% vs prior year% YoY
Net income
$126.00M
▲ +38.5% vs prior year% YoY
EPS
0.24$
▲ +33.3% vs prior year% YoY
Net margin
4.3%
▲ +1.0 percentage points vs prior year pp YoY
Revenue▲ +5.3 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +38.5 %
EPS▲ +33.3 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $2.96B | |
| Gross profit | $1.03B | 34.9 % |
| Operating income | $217.00M | 7.3 % |
| Net income | $126.00M | 4.3 % |
| R&D | $129.00M | 4.4 % |
| EPS (diluted) | 0.24 $ | |
| Balance sheet | ||
| Assets | $19.79B | |
| Liabilities | $13.61B | |
| Equity | $6.18B | |
| Cash | $2.15B | |
| Capital | ||
| Shares outstanding | 517.00M | as of 2026-07-23 |
| Public float | — | |